ElectroWire Medical Receives FDA Clearance for LightningWire™, Marking Latest Milestone for Lexington County Company

LEXINGTON, S.C. (July 17, 2026) – ElectroWire Medical has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its LightningWire™ Transseptal Puncture System, marking another milestone for the Lexington County-based medical device company as it prepares to bring its first product to market.

The clearance allows ElectroWire to begin commercializing the LightningWire™ system, which is designed to improve transseptal access during minimally invasive heart procedures. The technology is designed for compatibility with existing electrosurgical generators and a broad range of transseptal devices used in today’s cardiac procedures.

Since announcing plans to establish operations in Lexington County in December 2024, ElectroWire opened its manufacturing facility in August 2025, received FDA clearance for its first product and is now preparing for commercialization.

“ElectroWire was founded to set a new standard for transseptal access and device delivery,” said Dr. Robert Leonardi, founder of ElectroWire Medical. “We think we’ve done that with our LightningWire™ technology, which we expect to benefit patients, their physicians and the hospitals and ambulatory surgery centers where transseptal procedures are performed.”

ElectroWire plans to begin first-in-human procedures in August, followed by a limited market release in South Carolina and neighboring states later this year. A broader national rollout is anticipated in 2027 while the company continues generating clinical data to further demonstrate the technology’s safety, efficacy and clinical utility. 

“Receiving FDA clearance is an important step for ElectroWire and validates years of research, development and collaboration,” said Dr. Leonardi. “We’re excited to begin introducing LightningWire™ to physicians through a limited market release while continuing to generate clinical data that supports the technology and its potential to improve patient care.” 

For more information, visit https://electrowiremedical.com/. For updates, follow ElectroWire Medical on LinkedIn (https://www.linkedin.com/company/electrowire-corporation) and X (https://x.com/ElectroWire_Med).   

About ElectroWire Medical

ElectroWire Medical is a Lexington, S.C.-based medical device company developing technologies for cardiac electrophysiology and structural heart procedures. Founded by structural interventional cardiologist Dr. Robert Leonardi, the company is focused on advancing transseptal access and device delivery through innovative technologies designed to improve patient care. ElectroWire Medical is currently raising capital. Learn more at electrowiremedical.com.

###

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Paige Durham

SCbio is pleased to welcome Paige Durham to the team as communications coordinator to creatively and effectively communicate the value of the life science association’s programs and initiatives.

Durham will be responsible for developing and distributing high-quality content across multiple communications channels to build, advance and grow South Carolina’s life sciences industry, a key business sector for economic prosperity for the Palmetto State.

“SCbio is excited to welcome Paige to our team as our new communications coordinator. Paige brings fresh ideas and a strong background in communications that will be invaluable as we continue to strengthen our engagement with our audience,” said SCbio President and CEO James Chappell. “We are confident that her skills and experience will be crucial in advancing our communication strategies and supporting our mission.”

Before joining SCbio, Durham was the Membership and Communications Manager at the South Carolina Pharmacy Association (SCPhA), where she used her photography, design and writing skills to create content tailored to pharmacy professionals. Durham’s effective communication skills guaranteed the delivery of brand-specific material that captured the eye of her audience.

During her time at SCPhA, Durham created and edited the Palmetto Pharmacist Journal, using her creative vision to showcase members, educational institutions and industry news. Her communications efforts successfully gained new followers for the organization over the course of a year, increasing brand visibility and promoting the pharmacy profession.

Durham holds a Bachelor of Science in hospitality and tourism management and a Bachelor of Science in business administration from the College of Charleston.

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.